| Bio |
2017-Stage 2A nasal tip; wide excision and graft to nose; SLNB negative.
2020- Stage 4 w/bone mets. Pembrolizumab started 8/25/20. Braf neg.
2021- Complete metabolic response 6/17/21 (10 months)!
2022- End Pembro 1/18/22 after 18 months; staying on Xgeva for hx bone mets and osteoporosis. Surveillance CT scans every 3 months.
|
